Kodiak CMO Steps Down After Phase III Flops for Eye Therapy

Kodiak CMO Steps Down After Phase III Flops for Eye Therapy

Source: 
BioSpace
snippet: 

Kodiak Sciences’ Chief Medical Officer and Chief Development Officer Jason Ehrlich is stepping down from both of his positions, effective Aug. 25, the company announced in an SEC filing posted Thursday.